NYQ·Healthcare·$1.3B·#176 / 520 in Healthcare
ENOV Enovis Corporation
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH11
QUALITY62
STABILITY72
VALUATION100
GOVERNANCE40
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+6.7%
11
> 50% strong
Gross Margin
Revenue retained after direct costs
59.8%
85
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
92.6%
17
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.6x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
6
29
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
1.5%
12
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+0.7%
96
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ENOV WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ENOV's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.